Stroke, Ischemic
Description
A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. It is said to be the third leading cause of death in the United States. Gunel and Lifton (1996) noted that about 20% of strokes are hemorrhagic, resulting in bleeding into the brain. Ischemic strokes, resulting from vascular occlusion, account for the majority of strokes.Bersano et al. (2008) reviewed genetic polymorphisms that have been implicated in the development of stroke. Candidate genes include those involved in hemostasis (see, e.g., F5; {612309}), the renin-angiotensin-aldosterone system (see, e.g., ACE; {106180}), homocysteine (see, e.g., MTHFR; {607093}), and lipoprotein metabolism (see, e.g., APOE; {107741}).See also hemorrhagic stroke, or intracerebral hemorrhage (ICH ).
Clinical Features
Phenotypes and symptoms related to Stroke, Ischemic
- Stroke
- Cerebral hemorrhage
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Stroke, Ischemic Is also known as cerebral infarction, cerebrovascular accident.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Stroke, Ischemic Recommended genes panels
| Panel Name, Specifity and genes Tested/covered |
|---|
 F5.
By Molecular Diagnostic Laboratory University of Alberta (Canada).
F5
Specificity
100 %
Genes
25 % |
 Factor V Leiden Mutation Panel.
By Baylor Miraca Genetics Laboratories (United States).
F5
Specificity
100 %
Genes
25 % |
|
Thrombophilia Mutation Panel.
By Baylor Miraca Genetics Laboratories (United States).
F2, F5, MTHFR
Specificity
67 %
Genes
50 % |
|
Factor V Leiden.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
F5
Specificity
100 %
Genes
25 % |
|
Factor V Leiden.
By Center for Human Genetics, Inc (United States).
F5
Specificity
100 %
Genes
25 % |
|
Factor V Leiden Thrombophilia.
By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital (United States).
F5
Specificity
100 %
Genes
25 % |
|
Factor V Analysis.
By Molecular Pathology Laboratory University of Pennsylvania Health System (United States).
F5
Specificity
100 %
Genes
25 % |
 Factore V Leiden.
By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" (Argentina).
F5
Specificity
100 %
Genes
25 % |
You can get up to 162 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYOTONIA, POTASSIUM-AGGRAVATED EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD DUBIN-JOHNSON SYNDROME; DJS CYSTINOSIS, NEPHROPATHIC; CTNS THROMBOCYTOPENIA, CYCLIC MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4